Sodium–glucose cotransporter-2 inhibitor therapy and penile lichen sclerosus: Clinical observations suggesting a role in disease development through urinary occlusion
International Journal of STD & AIDS · 2026-07 · 37 (8) · 921-922
DOI: 10.1177/09564624261437602 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of STD & AIDS, online erschienen am 19.04.2026. Verfasst von Georgios Kravvas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicine, University College London, London, UK. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medicine, University College London, London, UK.
- Department of Dermatology, University College London, Hospitals NHS Foundation Trust, London, UK.
ORCID-Profile: Georgios Kravvas
Zitieren
APA
Kravvas, G., & Bunker, C. B. (2026). Sodium–glucose cotransporter-2 inhibitor therapy and penile lichen sclerosus: Clinical observations suggesting a role in disease development through urinary occlusion. International Journal of STD & AIDS, 37(8), 921-922. https://doi.org/10.1177/09564624261437602
Vancouver
Kravvas G, Bunker CB. Sodium–glucose cotransporter-2 inhibitor therapy and penile lichen sclerosus: Clinical observations suggesting a role in disease development through urinary occlusion. International Journal of STD & AIDS. 2026;37(8):921-922. doi:10.1177/09564624261437602
BibTeX
@article{Kravvas2026,
author = {Kravvas, Georgios and Bunker, Christopher Barry},
title = {Sodium–glucose cotransporter-2 inhibitor therapy and penile lichen sclerosus: Clinical observations suggesting a role in disease development through urinary occlusion},
journal = {International Journal of STD & AIDS},
year = {2026},
volume = {37},
number = {8},
pages = {921--922},
doi = {10.1177/09564624261437602}
}
EUVIMED